Alzheimer’s Disease (AD) likely isn't a primary neurodegenerative proteinopathy at all. Instead, it looks like a tertiary mechanical response to a failing "metabolic-kinetic sink" in the nasal epithelium. As we age, nasal mucociliary clearance (MCC) slows down—largely because the mitochondrial battery driving the cilia wears out. This creates a retrograde pressure gradient that effectively shuts down glymphatic drainage through the olfactory pathway. Within this framework, Amyloid-beta (Aβ) acts as a biological sealant to stop pathogens from crossing a leaky blood-brain barrier, while Tau hyperphosphorylation is a desperate attempt to stabilize axons struggling with the metabolic hypoxia that follows waste buildup.

The Nasal-Glymphatic Conduit

The olfactory epithelium is the only spot where the central nervous system sits just a few cell layers away from the outside world. We know a lot of CSF drains through the cribriform plate and into the nasal lymphatics. When MCC velocity drops—and research shows it correlates strongly with age (r = 0.64)—it physically blocks the "upstream" drainage of the brain’s waste products.

Aβ as a Sealant, not a Poison

It's telling that Aβ levels in the nasal epithelium don't differ much between AD patients and healthy controls. That’s because Aβ isn't just peripheral trash; it’s a centrally-deployed antimicrobial shield. When MCC stasis lets toxins and pathogens linger on the olfactory mucosa, the CNS triggers a "sealing" protocol. Aβ plaques act as a physical barrier to entomb these invaders. We've failed to cure AD because clearing this "rubble" without restoring the nose's kinetic flow just leaves the brain vulnerable to the same insults that started the process.

Tau as the Structural Compensator

While advanced tau pathology in the nose usually shows up late, the p-tau/t-tau ratio in nasal smears spikes much earlier. The microtubular disarrangement seen in aging nasal cilia is likely just the peripheral version of a systemic failure in microtubule stability. Tau hyperphosphorylation is an emergency response to keep the neuronal skeleton from collapsing under the osmotic pressure and metabolic acidosis of glymphatic stasis. It’s the sign of a cell trying to maintain its shape while its sewage system is backed up to the nose.

Synthesis

We've seen nasal MCC decline alongside early cognitive changes for years, but we’ve mostly treated them as separate issues. Cilia are some of the most metabolically expensive parts of the epithelium. When they fail, the kinetic energy needed to pull waste out of the brain disappears, creating a "stagnant pond" effect in the glymphatic system. This necessitates the emergency antimicrobial and structural fixes we currently call disease markers.

Testing the Model

This hypothesis is straightforward to test:

• Longitudinal Imaging: We can use contrast-enhanced MRI to track glymphatic outflow into the nasal lymphatics in patients with varying nasal MCC speeds (via saccharin tests). If glymphatic stasis consistently follows MCC decline but happens before plaques form, the hypothesis holds water.
• Mechanical Restoration: In animal models like 5xFAD mice, we could pharmacologically or mechanically speed up nasal MCC. If enhancing peripheral clearance reduces central Aβ buildup without any direct brain intervention, then the "Aβ as repair" model is validated.
• Falsification: If restoring nasal MCC doesn't change glymphatic flow, or if Aβ deposition happens without any upstream clearance dysfunction, the hypothesis is wrong.